BIIB

Biogen Inc. Common Stock

187.01

USD

BIIB Earnings Reports

Positive Surprise Ratio

BIIB beat 32 of 39 last estimates.

82%

Next Report

Date of Next Report

Jan 29, 2026

Estimate for Q4 25 (Revenue/ EPS)

$2.25B

$1.59

Implied change from Q3 25 (Revenue/ EPS)

-11.29%

-66.88%

Implied change from Q4 24 (Revenue/ EPS)

-8.40%

-53.78%

Biogen Inc. Common Stock earnings per share and revenue

On Oct 30, 2025, BIIB reported earnings of 4.80 USD per share (EPS) for Q3 25, beating the estimate of 3.95 USD, resulting in a 21.48% surprise. Revenue reached 2.53 billion, compared to an expected 2.39 billion, with a 6.24% difference. The market reacted with a +1.18% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 30 analysts forecast an EPS of 1.59 USD, with revenue projected to reach 2.25 billion USD, implying an decrease of -66.88% EPS, and decrease of -11.29% in Revenue from the last quarter.

FAQ

What were Biogen Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Biogen Inc. Common Stock reported EPS of $4.80, beating estimates by 21.48%, and revenue of $2.53B, 6.24% above expectations.

How did the market react to Biogen Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 1.18%, changed from $147.86 before the earnings release to $149.61 the day after.

When is Biogen Inc. Common Stock expected to report next?

The next earning report is scheduled for Jan 29, 2026.

What are the forecasts for Biogen Inc. Common Stock's next earnings report?

Based on 30 analysts, Biogen Inc. Common Stock is expected to report EPS of $1.59 and revenue of $2.25B for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.